The Reno biotech firm plans to submit its Ten Minute Tissue device for regulatory review in the first quarter of 2027.
Live Poll
Is now a good time for individual investors to participate in private company stock offerings?
October 6, 2026
Conexeu Sciences Advanced Wound Device ManufacturingThe Reno-based firm has scaled up production for its Ten Minute Tissue device ahead of a planned 2027 FDA filing.
October 1, 2026
Sarcomatrix Therapeutics Extended Investor Round ClosingThe Reno-based firm has pushed the deadline to October 31, 2026, to allow more time for investor due diligence.